GlassScriptPhysician profile
Joshua Preiss
NPI 1023495280
$12,493.48
in general payments reported to CMS, 2019-2025
9 companies · $746 in 2025
The $746 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,213 · 2023: $6,057 · 2024: $1,478 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $2,254 · Travel and Lodging: $2,017 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $2,254.11 |
| Travel and Lodging | $2,017.41 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,793.79 | 2022-2024 | Da Vinci Surgical System, Davinci Xi |
| Medtronic, INC. | $720.95 | 2023-2025 | Signia |
| Atricure, INC. | $502.97 | 2022-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Kls-Martin L.P. | $161.53 | 2025 | |
| Ethicon US, LLC | $123.96 | 2022-2025 | Echelon; Endopath |
| Baxter Healthcare | $107.10 | 2023 | Tisseel |
| Viiv Healthcare Company | $31.85 | 2025 | Apretude |
| Merck Sharp & Dohme LLC | $26.67 | 2025 | Lynparza, Keytruda Qlex, Keytruda |
| Davol INC. | $24.66 | 2025 | Progel Applicator Spray Tips |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Preiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.